Prescribing Vitamin D3 (Cholecalciferol) for Adults
Initial Assessment and Testing
Measure serum 25-hydroxyvitamin D [25(OH)D] before initiating treatment to establish baseline status and guide dosing. 1, 2
- Deficiency: <20 ng/mL – requires active treatment 1, 2
- Insufficiency: 20–30 ng/mL – consider treatment if risk factors present (osteoporosis, falls, elderly, CKD) 2
- Severe deficiency: <10–12 ng/mL – urgent treatment needed 1, 2
- Target level: ≥30 ng/mL for optimal bone health and anti-fracture efficacy 1, 2
- Upper safety limit: 100 ng/mL 1, 2
Loading Phase (For Deficiency <20 ng/mL)
Prescribe cholecalciferol (vitamin D3) 50,000 IU once weekly for 8–12 weeks. 1, 2
- Use 12 weeks for severe deficiency (<10 ng/mL) and 8 weeks for moderate deficiency (10–20 ng/mL) 1
- Cholecalciferol (D3) is strongly preferred over ergocalciferol (D2) because it maintains serum levels longer and has superior bioavailability 1, 2
- This regimen typically raises 25(OH)D by approximately 40–70 nmol/L (16–28 ng/mL) 1
Maintenance Phase (After Loading or for Insufficiency)
After completing the loading phase, transition to 1,500–2,000 IU daily. 2
Alternative maintenance options:
- 50,000 IU monthly (equivalent to ~1,600 IU daily) 1, 2
- 800–1,000 IU daily for elderly patients (≥65 years) as minimum dose 1, 2
- Higher doses (2,000–4,000 IU daily) may be needed for high-risk populations (obesity, malabsorption, CKD) 1
Special Populations
Elderly (≥65 years)
- Prescribe at least 800 IU daily even without baseline testing for dark-skinned, veiled, or institutionalized individuals 1, 2
- Higher doses (700–1,000 IU daily) reduce fall and fracture risk more effectively 1, 2
Chronic Kidney Disease (CKD stages 3–4)
- Use standard nutritional vitamin D (cholecalciferol or ergocalciferol), NOT active vitamin D analogs 1, 2
- CKD patients are at high risk due to reduced sun exposure, dietary restrictions, and urinary losses 1
Malabsorption (post-bariatric surgery, IBD, celiac disease)
- Consider intramuscular vitamin D3 50,000 IU if oral supplementation fails 1
- If IM unavailable, use substantially higher oral doses: 4,000–5,000 IU daily for 2 months 1
Monitoring Protocol
Recheck serum 25(OH)D after 3–6 months of treatment to ensure adequate response. 1, 2
- Vitamin D has a long half-life; measuring earlier will not reflect steady-state levels 1
- If using intermittent dosing (weekly/monthly), measure just before the next scheduled dose 1
- Once target (≥30 ng/mL) is achieved and stable, monitor annually 1
- Check serum calcium and phosphorus every 3 months during high-dose therapy to detect hypercalcemia 1
Essential Co-Interventions
Ensure adequate calcium intake of 1,000–1,500 mg daily from diet plus supplements. 1, 2
- Divide calcium supplements into doses ≤600 mg for optimal absorption 1, 2
- Recommend weight-bearing exercise 30 minutes, 3 days per week 2
Critical Pitfalls to Avoid
Never use active vitamin D analogs for nutritional deficiency
Do NOT prescribe calcitriol, alfacalcidol, doxercalciferol, or paricalcitol for nutritional vitamin D deficiency – they bypass normal regulation and increase hypercalcemia risk 1, 2
Avoid mega-doses
Do NOT give single doses >300,000 IU – they are inefficient and may increase fall/fracture risk 1, 2
Stop supplementation if hypercalcemia develops
Discontinue all vitamin D immediately if serum calcium exceeds 10.2 mg/dL (2.54 mmol/L) 1
Do not supplement patients with normal levels
Supplementation benefits are only seen in those with documented deficiency – not in individuals with normal levels 1, 2
Safety Considerations
- Daily doses up to 4,000 IU are completely safe for adults 1, 2, 3
- Toxicity is rare and typically occurs only with prolonged doses >10,000 IU daily or serum levels >100 ng/mL 1, 2
- Hypercalcemia, hyperphosphatemia, and suppressed PTH are signs of toxicity 1
Practical Prescribing Example
For a 55-year-old adult with 25(OH)D = 12 ng/mL (severe deficiency):
- Loading: Cholecalciferol 50,000 IU once weekly × 12 weeks
- Maintenance: Cholecalciferol 2,000 IU daily (or 50,000 IU monthly)
- Co-intervention: Calcium 1,200 mg daily (divided doses ≤600 mg)
- Monitoring: Recheck 25(OH)D at 3 months; target ≥30 ng/mL
- Long-term: Annual 25(OH)D monitoring once stable